We are live on
!
Find out more
NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
NVLN
Delisted
NVLN was delisted on the 8th of October, 2019.
53 hedge funds and large institutions have $53.6M invested in Novelion Therapeutics Inc. Common Shares in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
1% more capital invested
Capital invested by funds: $53.1M → $53.6M (+$503K)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
22% less funds holding
Funds holding: 68 → 53 (-15)
40% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 15
71% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 21
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $110K
Holders
53
Holders Change
-15
Holders Change %
-22.06%
% of All Funds
1.21%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
6
Increased
9
Reduced
15
Closed
21
Calls
–
Puts
$110K
Net Calls
-$110K
Net Calls Change
-$30K
Top Buyers
| 1 |
HVC
Healthcare Value Capital
Woodcliff Lake,
New Jersey
|
+$1.26M |
| 2 |
Millennium Management
New York
|
+$1.19M |
| 3 |
Goldman Sachs
New York
|
+$831K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$296K |
| 5 |
ECM
Element Capital Management
New York
|
+$247K |
Top Sellers
| 1 |
BlackRock
New York
|
-$2.56M |
| 2 |
State Street
Boston,
Massachusetts
|
-$768K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$465K |
| 4 |
O
OrbiMed
New York
|
-$350K |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$269K |
